Ho Maykin
SEC-identified person · CIK 1646395 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Agios Pharmaceuticals, INC. AGIO | Director | filed 2015 - 2026 |
| Kyntra BIO, INC. KYNB | Director | filed 2018 - 2026 |
| Biomarin Pharmaceutical INC BMRN | Director | filed 2021 - 2026 |
| Neumora Therapeutics, Inc. NMRA | Director | filed 2023 - 2026 |
| Parexel International Corp PRXL | Director | filed 2015 - 2017 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.